Research workbench
Catalytic domain of E. COLI RNase E in complex with 13-mer RNA
Analyse Catalytic domain of E. COLI RNase E in complex with 13-mer RNA in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 2C0B
- Type
- protein + RNA
- Length
- 498 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Ribonuclease E; 5'-R(*UP*UP*UP*AP*CP*AP*GP*UP*AP*UP*UP*UP*G)-3'
- EC
- 3.1.4.-
- UniProt
- P21513
- Ligands
- MG, ZN
- Pockets
- 6 · best druggability 0.82
Structure
x-ray diffraction · 2 distinct chains · 31% helix, 23% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| L | Ribonuclease E (EC 3.1.4.-) | protein | 488 | 31% helix, 23% strand | P21513 |
| R | 5'-R(*UP*UP*UP*AP*CP*AP*GP*UP*AP*UP*UP*UP*G)-3' | rna | 10 | — | — |
Ligands and binding sites
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 1171 | 0.82 | 0.83 | 119 | empty |
| 2 | 149 | 0.67 | 0.88 | 30 | empty |
| 3 | 323 | 0.64 | 0.80 | 41 | empty |
| 4 | 121 | 0.45 | 0.78 | 28 | empty |
| 5 | 95 | 0.40 | 0.77 | 18 | empty |
Interfaces
1 interface between chains.
- L–R · 1012 Ų buried · 26 hydrogen bonds · protein-nucleic
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P21513
- Elsewhere: RCSB PDB 2C0B · PDBe 2C0B · UniProt P21513
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.